Skip to Content

Frequently Searched

Supported by

Putting Bispecific T-Cell Engagers into Action

Last Updated: November 20, 2025

A guide for operationalizing BTCEs in your practice.

Download PDF Here

Find Similar Resources:

Immunotherapy
Immunotherapy

Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)

Last Updated: 02/19/2026
 Immunotherapy

Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings

Last Updated: 07/01/2025
 Immunotherapy

Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure

Last Updated: 07/01/2025
 Immunotherapy

Up Close with Linvoseltamab

Last Updated: 05/16/2025
PQI Podcast

S10 E5: Best Practices for Subcutaneous Administration of Anticancer Therapies

Last Updated: 03/23/2026
 Patient Education Sheet

Ibrutinib and Rituximab

Last Updated: 03/10/2026
 Patient Education Sheet

Acalabrutinib and BR

Last Updated: 03/10/2026
 Patient Education Sheet

Lenalidomide and Rituximab

Last Updated: 03/10/2026
Last Updated: 03/23/2026